BIOMAT Database Logo BIOMAT Database Logo

Osteoporosis markers on low-dose lung cancer screening chest computed tomography scans predict all-cause mortality. 2015

C F Buckens, and Y van der Graaf, and H M Verkooijen, and W P Mali, and I Isgum, and C P Mol, and H J Verhaar, and R Vliegenthart, and M Oudkerk, and C M van Aalst, and H J de Koning, and P A de Jong
Radiology Department, University Medical Center Utrecht, Heidelberglaan 100, E01.1A32, 3508 GA, Utrecht, The Netherlands.

OBJECTIVE Further survival benefits may be gained from low-dose chest computed tomography (CT) by assessing vertebral fractures and bone density. We sought to assess the association between CT-measured vertebral fractures and bone density with all-cause mortality in lung cancer screening participants. METHODS Following a case-cohort design, lung cancer screening trial participants (N = 3,673) who died (N = 196) during a median follow-up of 6 years (inter-quartile range: 5.7-6.3) were identified and added to a random sample of N = 383 from the trial. We assessed vertebral fractures using Genant's semiquantative method on sagittal reconstructions and measured bone density (Hounsfield Units (HU)) in vertebrae. Cox proportional hazards modelling was used to determine if vertebral fractures or bone density were independently predictive of mortality. RESULTS The prevalence of vertebral fractures was 35% (95% confidence interval 30-40%) among survivors and 51% (44-58%) amongst cases. After adjusting for age, gender, smoking status, pack years smoked, coronary and aortic calcium volume and pulmonary emphysema, the adjusted hazard ratio (HR) for vertebral fracture was 2.04 (1.43-2.92). For each 10 HU decline in trabecular bone density, the adjusted HR was 1.08 (1.02-1.15). CONCLUSIONS Vertebral fractures and bone density are independently associated with all-cause mortality. CONCLUSIONS • Lung cancer screening chest computed tomography contains additional, potentially useful information. • Vertebral fractures and bone density are independently predictive of mortality. • This finding has implications for screening and management decisions.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012907 Smoking Willful or deliberate act of inhaling and exhaling SMOKE from burning substances or agents held by hand. Smoking Behaviors,Smoking Habit,Behavior, Smoking,Behaviors, Smoking,Habit, Smoking,Habits, Smoking,Smoking Behavior,Smoking Habits
D014057 Tomography, X-Ray Computed Tomography using x-ray transmission and a computer algorithm to reconstruct the image. CAT Scan, X-Ray,CT Scan, X-Ray,Cine-CT,Computerized Tomography, X-Ray,Electron Beam Computed Tomography,Tomodensitometry,Tomography, Transmission Computed,X-Ray Tomography, Computed,CAT Scan, X Ray,CT X Ray,Computed Tomography, X-Ray,Computed X Ray Tomography,Computerized Tomography, X Ray,Electron Beam Tomography,Tomography, X Ray Computed,Tomography, X-Ray Computer Assisted,Tomography, X-Ray Computerized,Tomography, X-Ray Computerized Axial,Tomography, Xray Computed,X Ray Computerized Tomography,X Ray Tomography, Computed,X-Ray Computer Assisted Tomography,X-Ray Computerized Axial Tomography,Beam Tomography, Electron,CAT Scans, X-Ray,CT Scan, X Ray,CT Scans, X-Ray,CT X Rays,Cine CT,Computed Tomography, Transmission,Computed Tomography, X Ray,Computed Tomography, Xray,Computed X-Ray Tomography,Scan, X-Ray CAT,Scan, X-Ray CT,Scans, X-Ray CAT,Scans, X-Ray CT,Tomographies, Computed X-Ray,Tomography, Computed X-Ray,Tomography, Electron Beam,Tomography, X Ray Computer Assisted,Tomography, X Ray Computerized,Tomography, X Ray Computerized Axial,Transmission Computed Tomography,X Ray Computer Assisted Tomography,X Ray Computerized Axial Tomography,X Ray, CT,X Rays, CT,X-Ray CAT Scan,X-Ray CAT Scans,X-Ray CT Scan,X-Ray CT Scans,X-Ray Computed Tomography,X-Ray Computerized Tomography,Xray Computed Tomography
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

C F Buckens, and Y van der Graaf, and H M Verkooijen, and W P Mali, and I Isgum, and C P Mol, and H J Verhaar, and R Vliegenthart, and M Oudkerk, and C M van Aalst, and H J de Koning, and P A de Jong
Automatic opportunistic osteoporosis screening using low-dose chest computed tomography scans obtained for lung cancer screening.
July 2020, European radiology,
C F Buckens, and Y van der Graaf, and H M Verkooijen, and W P Mali, and I Isgum, and C P Mol, and H J Verhaar, and R Vliegenthart, and M Oudkerk, and C M van Aalst, and H J de Koning, and P A de Jong
Low-dose computed tomography screening reduces lung cancer mortality.
September 2018, Advances in medical sciences,
C F Buckens, and Y van der Graaf, and H M Verkooijen, and W P Mali, and I Isgum, and C P Mol, and H J Verhaar, and R Vliegenthart, and M Oudkerk, and C M van Aalst, and H J de Koning, and P A de Jong
Shedding Light on Incidental Findings on Low-Dose Lung Cancer Screening Chest Computed Tomography.
September 2017, Annals of the American Thoracic Society,
C F Buckens, and Y van der Graaf, and H M Verkooijen, and W P Mali, and I Isgum, and C P Mol, and H J Verhaar, and R Vliegenthart, and M Oudkerk, and C M van Aalst, and H J de Koning, and P A de Jong
Low-dose computed tomography lung cancer screening.
January 2014, Radiologic technology,
C F Buckens, and Y van der Graaf, and H M Verkooijen, and W P Mali, and I Isgum, and C P Mol, and H J Verhaar, and R Vliegenthart, and M Oudkerk, and C M van Aalst, and H J de Koning, and P A de Jong
Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.
August 2022, The Cochrane database of systematic reviews,
C F Buckens, and Y van der Graaf, and H M Verkooijen, and W P Mali, and I Isgum, and C P Mol, and H J Verhaar, and R Vliegenthart, and M Oudkerk, and C M van Aalst, and H J de Koning, and P A de Jong
Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography.
May 2008, British journal of cancer,
C F Buckens, and Y van der Graaf, and H M Verkooijen, and W P Mali, and I Isgum, and C P Mol, and H J Verhaar, and R Vliegenthart, and M Oudkerk, and C M van Aalst, and H J de Koning, and P A de Jong
Lung cancer screening with low-dose computed tomography.
April 2013, Journal of the National Comprehensive Cancer Network : JNCCN,
C F Buckens, and Y van der Graaf, and H M Verkooijen, and W P Mali, and I Isgum, and C P Mol, and H J Verhaar, and R Vliegenthart, and M Oudkerk, and C M van Aalst, and H J de Koning, and P A de Jong
Lung cancer screening with low-dose computed tomography.
January 2003, Seminars in roentgenology,
C F Buckens, and Y van der Graaf, and H M Verkooijen, and W P Mali, and I Isgum, and C P Mol, and H J Verhaar, and R Vliegenthart, and M Oudkerk, and C M van Aalst, and H J de Koning, and P A de Jong
Lung cancer screening with low-dose computed tomography.
June 2021, Nursing,
C F Buckens, and Y van der Graaf, and H M Verkooijen, and W P Mali, and I Isgum, and C P Mol, and H J Verhaar, and R Vliegenthart, and M Oudkerk, and C M van Aalst, and H J de Koning, and P A de Jong
Lung Cancer Screening With Low-Dose Computed Tomography.
June 2023, Deutsches Arzteblatt international,
Copied contents to your clipboard!